Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cryo Cell International (CCEL) Enterprise Value (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Enterprise Value for 16 consecutive years, with -$3.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Enterprise Value rose 5.72% to -$3.3 million in Q4 2025 year-over-year; TTM through Nov 2025 was -$3.3 million, a 5.72% increase, with the full-year FY2025 number at -$3.3 million, up 5.72% from a year prior.
  • Enterprise Value was -$3.3 million for Q4 2025 at Cryo Cell International, down from -$265207.0 in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$265207.0 in Q3 2025 to a low of -$11.4 million in Q1 2021.
  • A 5-year average of -$3.6 million and a median of -$2.7 million in 2022 define the central range for Enterprise Value.
  • Peak YoY movement for Enterprise Value: tumbled 256.66% in 2024, then soared 87.53% in 2025.
  • Cryo Cell International's Enterprise Value stood at -$8.3 million in 2021, then skyrocketed by 79.35% to -$1.7 million in 2022, then soared by 43.06% to -$980250.0 in 2023, then crashed by 256.66% to -$3.5 million in 2024, then rose by 5.72% to -$3.3 million in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Enterprise Value are -$3.3 million (Q4 2025), -$265207.0 (Q3 2025), and -$4.4 million (Q2 2025).